Information Exchange and Data Transformation (INFORMED), a multidisciplinary initiative anchored in the FDA Oncology Center of Excellence, is a decentralized science and technology incubator designed to harness the power of big data and advanced analytics to improve disease outcomes.
This is a preview of subscription content, log in via an institution to check access.
References
Khozin, S. Kim, G. & Pazdur, R. From big data to smart data: FDA's INFORMED initiative. Nat. Rev. Drug Discov. 16, 306 (2017).
Greene, J. A. & Loscalzo, J. Putting the patient back together — social medicine, network medicine, and the limits of reductionism. N. Engl. J. Med. 377, 2493–2499 (2017)10.1056/NEJMms1706744.
Bertagnolli, M. M. et al. Advantages of a truly open-access data-sharing model. N. Engl. J. Med. 376, 1178–1181 (2017)10.1056/NEJMsb1702054.
Khozin, S. et al. Evaluating the potential for digital submission of expedited premarket safety reports to the FDA. Nat. Rev. Drug Discov. 15, 670–671 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information
Traditional versus systems view of drug development (PDF 249 kb)
Related links
Rights and permissions
About this article
Cite this article
Khozin, S., Pazdur, R. & Shah, A. INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology. Nat Rev Drug Discov 17, 529–530 (2018). https://doi.org/10.1038/nrd.2018.34
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.34
- Springer Nature Limited
This article is cited by
-
Translational precision medicine: an industry perspective
Journal of Translational Medicine (2021)
-
A call for a global ‘bigger’ data approach to Alzheimer disease
Nature Reviews Drug Discovery (2019)